中文名 | CS-2826 |
英文名 | BB-Cl-Amidine |
别名 | 化合物BB-CL-AMIDINE (S)-N-(1-(1H-苯并[D]咪唑-2-基)-4-(2-氯乙酰亚胺基)丁基)-[1,1'-联苯基]-4-甲酰胺 |
英文别名 | CS-2826 BB-Cl-Amidine N-{(1S)-1-(1H-Benzimidazol-2-yl)-4-[(2-chloroethanimidoyl)amino]butyl}-4-biphenylcarboxamide [1,1'-Biphenyl]-4-carboxamide, N-[(1S)-1-(1H-benzimidazol-2-yl)-4-[(2-chloro-1-iminoethyl)amino]butyl]- |
CAS | 1802637-39-3 |
化学式 | C26H26ClN5O |
分子量 | 459.971 |
存储条件 | Inert atmosphere,Store in freezer, under -20°C |
体内研究 | Treatment with BB-Cl-amidine subtly reduces splenomegaly in MRL/lpr mice, while there is a trend towards increased circulating levels of anti-NET antibodies with PAD inhibitor treatment. However, neither PAD inhibitor affected body weight or total IgG levels. Indeed, treatment with both Cl-amidine and BB-Cl-amidine significantly improves endothelium-dependent vasorelaxation. The BB-Cl-amidine group also shows a strong trend towards downregulation of IRGs. Treatment with either Cl-amidine or BB-Cl-amidine significantly improves muzzle alopecia, in many cases preventing it entirely. Animal Model: MRL/lpr mice. Dosage: 1 mg/kg. Administration: Subcutaneous injection daily from 8 to 14 weeks of age. Result: Significantly improved endothelium-dependent vasorelaxation and showed a strong trend towards downregulation of IRGs. |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!